CompletedNot Applicable

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

France5,197 participantsStarted 2020-10-19

Plain-language summary

The investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult or child subject able to receive nasopharyngeal swab, regardless of age * Subject in whom nasopharyngeal swab is performed for detection of SARS-CoV-2 as part of the screening system managed by APHP * Subject or parent not opposed to saliva sampling and data collection as part of this research Exclusion Criteria: * None

What they're measuring

Positivity of RT-PCR on nasopharyngeal swab for the SARS-CoV-2 virus

Timeframe: At diagnosis

Trial details

NCT IDNCT04578509

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-06-09

View on ClinicalTrials.gov More SARS-CoV-2 Infection trials